Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Breast cancer research and treatment

Results: 1-25/174

Authors: Barnes, DM Gillett, CE
Citation: Dm. Barnes et Ce. Gillett, Cyclin D1 in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 1-15

Authors: Steeg, PS Zhou, Q
Citation: Ps. Steeg et Q. Zhou, Cyclins and breast cancer, BREAST CANC, 52(1-3), 1998, pp. 17-28

Authors: Cariou, S Catzavelos, C Slingerland, JM
Citation: S. Cariou et al., Prognostic implications of expression of the cell cycle inhibitor protein p27(Kip1), BREAST CANC, 52(1-3), 1998, pp. 29-41

Authors: Gullick, WJ Srinivasan, R
Citation: Wj. Gullick et R. Srinivasan, The type 1 growth factor receptor family: new ligands and receptors and their role in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 43-53

Authors: De Placido, S Carlomagno, C De Laurentiis, M Bianco, AR
Citation: S. De Placido et al., c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients, BREAST CANC, 52(1-3), 1998, pp. 55-64

Authors: Pegram, MD Pauletti, G Slamon, DJ
Citation: Md. Pegram et al., HER-2/neu as a predictive marker of response to breast cancer therapy, BREAST CANC, 52(1-3), 1998, pp. 65-77

Authors: Elledge, RM Allred, DC
Citation: Rm. Elledge et Dc. Allred, Prognostic and predictive value of p53 and p21 in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 79-98

Authors: Stephens, RW Brunner, N Janicke, F Schmitt, M
Citation: Rw. Stephens et al., The urokinase plasminogen activator system as a target for prognostic studies in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 99-111

Authors: Toi, M Ishigaki, S Tominaga, T
Citation: M. Toi et al., Metalloproteinases and tissue inhibitors of metalloproteinases, BREAST CANC, 52(1-3), 1998, pp. 113-124

Authors: Brown, PD
Citation: Pd. Brown, Matrix metalloproteinase inhibitors, BREAST CANC, 52(1-3), 1998, pp. 125-136

Authors: Menard, S Tagliabue, E Colnaghi, MI
Citation: S. Menard et al., The 67 kDa laminin receptor as a prognostic factor in human cancer, BREAST CANC, 52(1-3), 1998, pp. 137-145

Authors: Heimann, R Ferguson, D Gray, S Hellman, S
Citation: R. Heimann et al., Assessment of intratumoral vascularization (angiogenesis) in breast cancerprognosis, BREAST CANC, 52(1-3), 1998, pp. 147-158

Authors: Locopo, N Fanelli, M Gasparini, G
Citation: N. Locopo et al., Clinical significance of angiogenic factors in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 159-173

Authors: Ellis, MJ Jenkins, S Hanfelt, J Redington, ME Taylor, M Leek, R Siddle, K Harris, A
Citation: Mj. Ellis et al., Insulin-like growth factors in human breast cancer, BREAST CANC, 52(1-3), 1998, pp. 175-184

Authors: Dahiya, R Deng, GR
Citation: R. Dahiya et Gr. Deng, Molecular prognostic markers in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 185-200

Authors: Braun, S Pantel, K
Citation: S. Braun et K. Pantel, Prognostic significance of micrometastatic bone marrow involvement, BREAST CANC, 52(1-3), 1998, pp. 201-216

Authors: Jatoi, I
Citation: I. Jatoi, Timing of surgery for primary breast cancer with regard to the menstrual phase and prognosis, BREAST CANC, 52(1-3), 1998, pp. 217-225

Authors: Hilsenbeck, SG Ravdin, PM de Moor, CA Chamness, GC Osborne, CK Clark, GM
Citation: Sg. Hilsenbeck et al., Time-dependence of hazard ratios for prognostic factors in primary breast cancer, BREAST CANC, 52(1-3), 1998, pp. 227-237

Authors: Stearns, V Yamauchi, H Hayes, DF
Citation: V. Stearns et al., Circulating tumor markers in breast cancer: Accepted utilities and novel prospects, BREAST CANC, 52(1-3), 1998, pp. 239-259

Authors: Henderson, IC Patek, AJ
Citation: Ic. Henderson et Aj. Patek, The relationship between prognostic and predictive factors in the management of breast cancer, BREAST CANC, 52(1-3), 1998, pp. 261-288

Authors: Altman, DG Lyman, GH
Citation: Dg. Altman et Gh. Lyman, Methodological challenges in the evaluation of prognostic factors in breast cancer, BREAST CANC, 52(1-3), 1998, pp. 289-303

Authors: Hayes, DF Trock, B Harris, AL
Citation: Df. Hayes et al., Assessing the clinical impact of prognostic factors: When is "statistically significant" clinically useful?, BREAST CANC, 52(1-3), 1998, pp. 305-319

Authors: Gasparini, G
Citation: G. Gasparini, Prognostic variables in node-negative and node-positive breast cancer, BREAST CANC, 52(1-3), 1998, pp. 321-331

Authors: Gasparini, G
Citation: G. Gasparini, Prognostic variables in node-negative and node-positive breast cancer - Introduction, BREAST CANC, 51(3), 1998, pp. 193-194

Authors: Page, DL Jensen, RA Simpson, JF
Citation: Dl. Page et al., Routinely available indicators of prognosis in breast cancer, BREAST CANC, 51(3), 1998, pp. 195-208
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>